Human Medicine:

Latent Tuberculosis Infection (LTBI) Testing

SYNLAB specialises in providing end to end services for the diagnosis of Latent Tuberculosis Infection (LTBI) in accordance with UK government guidelines, and is experienced in carrying out a broad range of pathology services in support of clinical trials.

LTBI screening can help prevent the spread of Tuberculosis (TB), with early detection improving treatment outcomes. Screening days and individual test options available.

  • 1 in 4 people worldwide estimated to have latent TB infection, 5-10% of which likely to develop active TB within 5 years if left untreated*
  • Gamma Release Assays (IGRAs) test supporting the NICE guidelines for TB screening
  • People with LTBI typically have no symptoms or physical findings suggestive of TB disease
  • Screening day project set up and management services, including provision of kits and phlebotomist
Screening Test for High Risk Populations

High risk populations include those with weakened immune systems, in recent contact with TB infection, recent travel to countries / areas with TB outbreaks, live or work in high risk settings such as prisons, healthcare / nursing homes and shelters, as well as educational institutes. In addition:

  • People in hard to reach groups
  • Anyone aged 5 years and older in an outbreak situation where a large number of contacts need to be tested
  • New NHS healthcare workers, if they have recently arrived from high incidence countries, or if they have had contact with patients in settings where TB is highly prevalent
  • Immunocompromised patients with HIV and CD4 counts < 500 cells/mm3
  • Immunocompromised patients with prolonged steroid use, use of TNF alpha antagonists or drugs used to prevent rejection of transplanted organs

Contact Us to find out more about SYNLAB’s LTBI screening services.

* Source: World Health Organization

Latest Human Medicine News
Important statement: Pathology First

We are aware that, in recent days, a media report has been published regarding our Pathology First partnership with Mid and South Essex NHS Foundation…

Read More (about 'Important statement: Pathology First')
Pathology laboratory becomes the first in the UK to support remote plate reading  

A pathology laboratory is leading the way in speeding up access to patient care and treatment after becoming the first in the UK to enable…

Read More (about 'Pathology laboratory becomes the first in the UK to support remote plate reading  ')
SYNLAB UK & Ireland to showcase biomedical science career opportunities during IBMS Congress

Leading pathology provider SYNLAB UK & Ireland is looking forward to welcoming biomedical scientists to its stand at the IBMS Congress 2022 next week. Representatives…

Read More (about 'SYNLAB UK & Ireland to showcase biomedical science career opportunities during IBMS Congress')
Case Studies

At SYNLAB we are very proud of the services we provide with our NHS partners. Our involvement has enabled the service to realise many improvements…

Read More (about 'Case Studies')
Stella with Staff
Hares About Town

Pathology First Sponsors Stella, The Disco Hare Pathology First is the proud sponsor of Stella the Disco Hare as part of the spectacular public art…

Read More (about 'Hares About Town')
New Pathology Partnership to Transform Patient Care in UK Capital

A partnership that will transform pathology services and help to improve the quality of patient care across South East London has today gone live. Over…

Read More (about 'New Pathology Partnership to Transform Patient Care in UK Capital')